Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020
- PMID: 34399040
- PMCID: PMC8626596
- DOI: 10.1002/cac2.12207
Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020
Abstract
Background: Breast cancer is the most commonly diagnosed cancer and leading cause of cancer death among women worldwide but has patterns and trends which vary in different countries. This study aimed to evaluate the global patterns of breast cancer incidence and mortality and analyze its temporal trends for breast cancer prevention and control.
Methods: Breast cancer incidence and mortality data in 2020 were obtained from the GLOBOCAN online database. Continued data from the Cancer Incidence in Five Continents Time Trends, the International Agency for Research on cancer mortality and China National Central Cancer Registry were used to analyze the time trends from 2000 to 2015 through Joinpoint regression, and annual average percent changes of breast cancer incidence and mortality were calculated. Association between Human Development Index and breast cancer incidence and mortality were estimated by linear regression.
Results: There were approximately 2.3 million new breast cancer cases and 685,000 breast cancer deaths worldwide in 2020. Its incidence and mortality varied among countries, with the age-standardized incidence ranging from the highest of 112.3 per 100,000 population in Belgium to the lowest of 35.8 per 100,000 population in Iran, and the age-standardized mortality from the highest of 41.0 per 100,000 population in Fiji to the lowest of 6.4 per 100,000 population in South Korea. The peak age of breast cancer in some Asian and African countries were over 10 years earlier than in European or American countries. As for the trends of breast cancer, the age-standardized incidence rates significantly increased in China and South Korea but decreased in the United States of America (USA) during 2000-2012. Meanwhile, the age-standardized mortality rates significantly increased in China and South Korea but decreased in the United Kingdom, the USA, and Australia during 2000 and 2015.
Conclusions: The global burden of breast cancer is rising fast and varies greatly among countries. The incidence and mortality rates of breast cancer increased rapidly in China and South Korea but decreased in the USA. Increased health awareness, effective prevention strategies, and improved access to medical treatment are extremely important to curb the snowballing breast cancer burden, especially in the most affected countries.
Keywords: Breast cancer; cancer registry; cancer trends; incidence; mortality; patterns; time trends.
© 2021 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat-sen University Cancer Center.
Conflict of interest statement
No potential conflicts of interest are disclosed.
Figures
![FIGURE 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c000/8626596/c93bf09315e0/CAC2-41-1183-g001.gif)
![FIGURE 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c000/8626596/bf0a7ebaa325/CAC2-41-1183-g003.gif)
![FIGURE 3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c000/8626596/3bcc866f4d71/CAC2-41-1183-g002.gif)
![FIGURE 4](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c000/8626596/ae9c24d50d9f/CAC2-41-1183-g004.gif)
![FIGURE 5](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c000/8626596/5438f620c8ed/CAC2-41-1183-g005.gif)
Similar articles
-
Global burden and trends of lung cancer incidence and mortality.Chin Med J (Engl). 2023 Jul 5;136(13):1583-1590. doi: 10.1097/CM9.0000000000002529. Chin Med J (Engl). 2023. PMID: 37027426 Free PMC article.
-
Cancer statistics in China and United States, 2022: profiles, trends, and determinants.Chin Med J (Engl). 2022 Feb 9;135(5):584-590. doi: 10.1097/CM9.0000000000002108. Chin Med J (Engl). 2022. PMID: 35143424 Free PMC article.
-
Global and regional trends in incidence and mortality of female breast cancer and associated factors at national level in 2000 to 2019.Chin Med J (Engl). 2022 Jan 5;135(1):42-51. doi: 10.1097/CM9.0000000000001814. Chin Med J (Engl). 2022. PMID: 34593698 Free PMC article.
-
International variations and trends in renal cell carcinoma incidence and mortality.Eur Urol. 2015 Mar;67(3):519-30. doi: 10.1016/j.eururo.2014.10.002. Epub 2014 Oct 16. Eur Urol. 2015. PMID: 25449206 Review.
-
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.Eur Urol. 2017 Jan;71(1):96-108. doi: 10.1016/j.eururo.2016.06.010. Epub 2016 Jun 28. Eur Urol. 2017. PMID: 27370177 Review.
Cited by
-
Deciphering the Role and Signaling Pathways of PKCα in Luminal A Breast Cancer Cells.Int J Mol Sci. 2022 Nov 14;23(22):14023. doi: 10.3390/ijms232214023. Int J Mol Sci. 2022. PMID: 36430510 Free PMC article.
-
Comprehensive Retrospective Analysis of Colorectal Cancer Incidence Patterns in Saudi Arabia.Life (Basel). 2023 Nov 11;13(11):2198. doi: 10.3390/life13112198. Life (Basel). 2023. PMID: 38004338 Free PMC article.
-
Clinical Characteristics, Prognostic Factors and Treatment Outcomes of Patients with Bone-Only Metastatic Breast Cancer.Cancer Manag Res. 2022 Aug 23;14:2519-2531. doi: 10.2147/CMAR.S369910. eCollection 2022. Cancer Manag Res. 2022. PMID: 36039341 Free PMC article.
-
Breast cancer: Epidemiology, risk factors and screening.Chin J Cancer Res. 2023 Dec 30;35(6):565-583. doi: 10.21147/j.issn.1000-9604.2023.06.02. Chin J Cancer Res. 2023. PMID: 38204449 Free PMC article.
-
Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.JAMA Netw Open. 2023 Nov 1;6(11):e2342107. doi: 10.1001/jamanetworkopen.2023.42107. JAMA Netw Open. 2023. PMID: 37966841 Free PMC article. Clinical Trial.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021. - PubMed
-
- Soerjomataram I, Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020‐2070. Nat Rev Clin Oncol. 2021. - PubMed
-
- International Agency for Research on Cancer . Agents classified by the IARC monographs on the evaluation of carcinogenic risks to humans. http://monographs.iarc.fr/ENG/Classification/.
-
- Britt KL, Cuzick J, Phillips KA. Key steps for effective breast cancer prevention. Nat Rev Cancer. 2020;20(8):417‐36. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials